Article Text
Colorectal
Pharmacy-led switches of 5-ASA: impact on secondary care
Statistics from Altmetric.com
Footnotes
Contributors CJH and JO'M hereby confirm that they contributed to the development of this manuscript as authors, contributing to its conception and preparation and providing final approval of the manuscript. Editorial assistance was provided by Acumen Healthcare Communications.
Funding Warner Chilcott UK Ltd sponsored the preparation of this article and contributed to its development.
Competing interests Dr Healey has received sponsorship for meetings from Warner Chilcott UK Ltd, and has acted as a clinical advisor to Ferring Pharmaceuticals Ltd. Dr O'Malley has received sponsorship for meetings from Warner Chilcott UK Ltd.
Provenance and peer review Not commissioned; externally peer reviewed.